Neurostimulation Market Forecast and Segments, 2012 - 2018
Medical devices manufacturing companies and their technological affiliates or subsidiaries are continuously working on developing novel devices and technologies which can enhance the efficacy of existing treatments and devices, and simultaneously gain market advantage. The strategic approaches followed by these companies are focusing on creating new markets and increasing the existing market share. The market is driven by rising cases of neurological disorders such as Parkinson’s disease, epilepsy, chronic pain and incidences of depression related disorders.
Obtain Report Details @ https://www.transparencymarketresearch.com/neurostimulation-market.html
The need for devices with better user interface, ability to pre-sense a neurological episode on-set, optimize the inter-device communication, and many more such features which can increase the therapeutic efficacy of the therapy, is driving the neurostimulation market growth. However, lack of a reliable measuring system which can define the expected outcome of neurostimulation therapies is a major challenge for manufacturers to develop a solution with defined outcome.
The neurostimulation market based on therapies is broadly categorized into the following segments: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), and Vagus Nerve Stimulation (VNS). The slow pace of technological developments in the field is limiting the market growth, and in the current global market has the following technologies - Navigated Brain Stimulation (NBS), Transcranial Magnetic Stimulation (TMS), VNS, DBS, and SCS. However, with stringent IP regulations and increase in FDA approvals, the market is set to see quick growth in the near future.
The market for neurostimulation currently has strong presence in North America and Europe, but is experiencing fast growth in Asia Pacific regions, mainly across China, Brazil and the Indian markets.
Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=774
The global neurological market currently has few players who are largely present in Western markets. The leading players dominating the market are - Boston Scientific Corp., Cyberonics Inc., St. Jude Medical Inc., Medtronic Inc., Neuropace Inc., and CVRx Inc.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurostimulation Market Forecast and Segments, 2012 - 2018 here
News-ID: 879709 • Views: 238
More Releases from Transparency Market Research
Meningitis Diagnostic Testing Market Outlook, Trend, Growth and Share Estimation …
Meningitis Diagnostic Testing Market: Overview The global meningitis diagnostic testing market was valued over US$ 105.5 Mn in 2016 and is projected to register cumulative annual growth rate (CAGR) of over 3.0% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled "Meningitis Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017-2025". The report suggests that rising demand for innovative
Metformin Hydrochloride API Market to Expand at a CAGR of ~5% from 2021 to 2031
Metformin Hydrochloride API Market: Introduction According to the report, the global metformin hydrochloride API market was valued at ~US$ 300 Mn in 2020 and is projected to expand at a CAGR of ~5% from 2021 to 2031. Metformin hydrochloride is primarily used in the treatment of diabetes. The prevalence of diabetes is expected to increase across the world due to change in lifestyle and factors such as malnutrition and genetic mutations.
Telehealth Market to Reach the Value of US$ 15 Bn by the End of 2028
Telehealth Market: Introduction According to the report, the global telehealth market was valued at US$ 7.8 Bn in 2020 and is projected to expand at a CAGR of 7% from 2021 to 2028. The global telehealth market has witnessed strong growth in the past few years. Telehealth is no longer an option, but a necessity due to the increasing dangers of COVID-19. Read Report Overview - https://www.transparencymarketresearch.com/telehealth-market.html The crisis presents an opportunity
Lyme Disease Treatment Market Growth Trends, Current Demand, and Development Rep …
Lyme Disease Treatment Market: Introduction According to the report, the global Lyme disease treatment market was valued at US$ 1.58 Bn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031. Increase in pet ownership, surge in awareness & adoption of veterinary care, and rise in healthcare expenditure on animals are anticipated to drive the global Lyme disease treatment market from 2021 to 2031.North America
More Releases for Stimulation
Global Stimulation Materials Sales Market Report 2018
In this report, the global Stimulation Materials market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Stimulation Materials for these regions, from 2013 to 2025 (forecast),
Global Sacral Nerve Stimulation Devices Market | MarketResearchReports.biz
Latest industry research report on: Global Sacral Nerve Stimulation Devices Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report offers a comprehensive analysis of the Sacral Nerve Stimulation Devices Market players with all the major trends in the market. In this report, growth of the Sacral Nerve Stimulation Devices Market is estimated for the forecast period 2017-2022 in terms of CAGR % and the
Medical Electrical Stimulation Devices market 2017-2022
Research Trades Highlights Market Insights on "Medical Electrical Stimulation Devices market 2017-2022" In this report, the global Medical Electrical Stimulation Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and
Oilfield Stimulation Chemicals Market to Grow Globally
The process of oilfield stimulation is primarily used for recovery and improvement in the flow of hydrocarbons from drilling wells. With advancements in technology and innovations in chemical industry, oilfield stimulation process has become extremely less cumbersome. Various chemicals are applied for different processes of oil extraction, such as biocides, water control polymers, acids, gelling agents/viscosities, corrosion inhibitors, friction reducers, breaker, and iron control agents. Among these, gelling agents are
Europe Muscle Stimulation Devices Market Report 2017
MarketResearchReports.Biz presents this most up-to-date research on "Europe Muscle Stimulation Devices Market Report 2017" Description This report studies sales (consumption) of Muscle Stimulation Devices in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering DJO Global Zynex NeuroMetrix RS Medical Omron Market Segment by Countries, this report splits Europe into several key Countries, with
Global Deep Brain Stimulation Market 2016-2020
About Deep Brain Stimulation A neurostimulation system, also known as a neurostimulator, provides therapeutic activation or modulation in the nervous system at targeted anatomical sites. Deep brain stimulation (DBS) system, a type of neurostimulator, generates electrical stimulation to the targeted areas of the brain and regulates the electrical signals that are generated by the diseased brain cells and neurons. Technavios analysts forecast the global DBS market to grow at a CAGR of